Abbott Laboratories
NYSE:ABT

Watchlist Manager
Abbott Laboratories Logo
Abbott Laboratories
NYSE:ABT
Watchlist
Price: 128.51 USD -0.67% Market Closed
Market Cap: 222.9B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one ABT stock under the Base Case scenario is 128.59 USD. Compared to the current market price of 128.51 USD, Abbott Laboratories is Fairly Valued.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABT Relative Value
Base Case
128.59 USD
Fairly Valued
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

5.3
P/S
P/S
Price to Sales
5.3
vs History
15
vs Industry
25
Median 3Y
4.5
Median 5Y
4.7
Industry
2.2
Forward
5
More Details
16.5
P/E
P/E
Price to Earnings
16.5
vs History
95
vs Industry
31
Median 3Y
29.9
Median 5Y
32.3
Industry
21.8
Forward
24.7
More Details
26
P/OCF
P/OCF
Price to OCF
26
vs History
15
vs Industry
14
Median 3Y
23.4
Median 5Y
22.9
Industry
13.4
More Details
47.3
P/FCFE
P/FCFE
Price to FCFE
47.3
vs History
28
vs Industry
9
Median 3Y
34.9
Median 5Y
34.8
Industry
19
More Details
4.7
P/B
P/B
Price to Book Value
4.7
vs History
76
vs Industry
17
Median 3Y
4.9
Median 5Y
5
Industry
2.1
More Details
5.4
EV/S
EV/S
Enterprise Value to Sales
5.4
vs History
22
vs Industry
23
Median 3Y
4.6
Median 5Y
4.9
Industry
2.3
Forward
5.1
More Details
9.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.6
vs History
23
vs Industry
22
Median 3Y
8.3
Median 5Y
8.7
Industry
4.8
More Details
21.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
21.4
vs History
19
vs Industry
15
Median 3Y
18.6
Median 5Y
19.4
Industry
11.4
Forward
19
More Details
30.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
30.7
vs History
25
vs Industry
13
Median 3Y
28.1
Median 5Y
28.8
Industry
15.5
Forward
21.9
More Details
26.5
EV/OCF
EV/OCF
Enterprise Value to OCF
26.5
vs History
22
vs Industry
14
Median 3Y
24.2
Median 5Y
23.4
Industry
13.3
More Details
35.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
35.8
vs History
30
vs Industry
13
Median 3Y
32.5
Median 5Y
32.5
Industry
17.1
More Details
3.3
EV/IC
EV/IC
Enterprise Value to IC
3.3
vs History
30
vs Industry
25
Median 3Y
3.2
Median 5Y
3.2
Industry
1.8
More Details

Multiples Across Competitors

ABT Competitors Multiples
Abbott Laboratories Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Abbott Laboratories
NYSE:ABT
222.5B USD 5.3 16.5 21.4 30.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.3B USD 21 74 59 71
US
Boston Scientific Corp
NYSE:BSX
150.1B USD 9 81 37 52.2
US
Stryker Corp
NYSE:SYK
139.2B USD 6.2 46.5 24.1 29.1
IE
Medtronic PLC
NYSE:MDT
107.6B USD 3.2 25.3 13.5 19.1
DE
Siemens Healthineers AG
XETRA:SHL
52.4B EUR 2.3 26.4 15.3 21.8
US
Becton Dickinson and Co
NYSE:BDX
59.5B USD 2.9 34 14.5 26.1
US
Edwards Lifesciences Corp
NYSE:EW
44.5B USD 8.2 10.7 25.1 27.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
263.1B CNY 7.1 21.2 18.4 18.4
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.6B USD 9.1 40.1 28.5 31.8
US
Resmed Inc
NYSE:RMD
34.6B USD 6.9 26.4 18.8 21.3

See Also

Summary
ABT intrinsic value, competitors valuation, and company profile.
DCF Valuation
ABT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ABT stock valuation using valuation multiples.
Wall Street Estimates
ABT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ABT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 248,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.